Morning Overview

Health

The FDA cleared donor immune cells to shield blood-cancer patients from deadly complications

Adults with blood cancers who need a stem-cell transplant from a matched donor now have a new option to prevent one of the procedure’s most dangerous aftereffects. The FDA approved Tregzi, a donor-derived regulatory T-cell therapy made by Orca Bio, to reduce the risk of graft-versus-host disease (GVHD) in adults undergoing allogeneic hematopoietic stem-cell transplantation […]